Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10036038 HIV pre-immunization and immunotherapy

Patent 10036038 was granted and assigned to American Gene Technologies on July, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

American Gene Technologies

0

Current Assignee

American Gene Technologies

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jeff Galvin0

Haishan Li0

Tyler Lahusen0

Charles David Pauza0

Date of Patent

July 31, 2018

0

Patent Application Number

156682230

Date Filed

August 3, 2017

0

Patent Citations Received

US Patent 12090200 Methods of producing cells resistant to HIV infection

0

US Patent 10888613 Method of producing cells resistant to HIV infection

0

US Patent 11583562 Viral vectors for treating Parkinson's disease

US Patent 10975374 Combination vectors and methods for treating cancer

US Patent 11007209 Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules

US Patent 11911458 HIV pre-immunization and immunotherapy

0

US Patent 11976292 Non-integrating viral delivery system and methods related thereto

0

US Patent 11980663 HIV pre-immunization and immunotherapy

0

...

Patent Primary Examiner

Barry A Chestnut

0

Patent abstract

The present invention relates generally to immunization and immunotherapy for the treatment or prevention of HIV. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10036038 HIV pre-immunization and immunotherapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool